Results 231 to 240 of about 5,025,784 (284)
ChemInform Abstract: Bromodecarboxylation of Quinoline Salicylic Acids: Increasing the Diversity of Accessible Substituted Quinolines. [PDF]
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Neelu Kaila, Kristin Janz
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Production of Quinolinic Acid and Kynurenic Acid by Human Glioma
1991Using biochemical and immunohistochemical techniques, the biosynthesis of the excitotoxin quinolinic acid (QUIN) and the anti-excitotoxin kynurenic acid (KYNA) in the rat brain has been demonstrated to take place preferentially in glial cells (see Schwarcz and Du, this volume, for review). Although a dysfunction of either of these two brain metabolites
Vezzani, A+3 more
openaire +4 more sources
Quinolinic Acid Phosphoribosyltransferase in Rat Brain
Journal of Neurochemistry, 1985Abstract: Because of the possible participation of quinolinic acid in brain function and/or dysfunction, the characteristics of its catabolic enzyme, quinolinic acid phosphoribosyltransferase (QPRTase; EC 2.4.2.19), were examined in rat brain tissue. For this purpose, a sensitive radiochemical assay method, based on the conversion of quinolinic acid ...
Alan C. Foster+2 more
openaire +2 more sources
The quinolinic acid hypothesis in Huntington's chorea
Journal of the Neurological Sciences, 1990In the central nervous system and particularly in the striatum of patients with Huntington's disease (HD) a dramatic cell loss can be observed. Animal models of HD are based on intrastriatal injection of excitatory amino acids (EAAs). Stimulation of EAA receptors for a prolonged period of time degenerates the cells on which the EAA receptors are ...
R.P.M. Bruyn, J.C. Stoof
openaire +3 more sources
Brain Quinolinic Acid in Huntington's Disease
Journal of Neurochemistry, 1988Abstract: Concentrations of the endogenous neurotoxic tryptophan metabolite, quinolinic acid (QA), were measured in postmortem brain tissue obtained from patients with Huntington's disease (HD) and matched controls, using a gas chromatography/mass spectrometry method.
Gavin P. Reynolds+3 more
openaire +2 more sources
Quinolinic acid in children with congenital hyperammonemia
Annals of Neurology, 1993AbstractLevels of the excitotoxin quinolinic acid (QUIN) were measured in the cerebrospinal fluid of infants and children with congenital hyperammonemia. Twofold to tenfold elevations of QUIN were found in 4 neonates in hyperammonemic coma (QUIN range, 250–990 nM; control mean, 110 ± 90 nM; p < 0.005).
Michael B. Robinson+4 more
openaire +3 more sources
A photometric method for the determination of quinolinic acid
Archives of Biochemistry and Biophysics, 1953Abstract 1. 1. A photometric method is described for the determination of quinolinic acid in trichloroacetic acid extracts of tissue preparations which have metabolized 3-hydroxyanthranilic acid. 2. 2. The method is based on the measurement of the stable yellow color of the ferrous chelate of quinolinic acid.
M. Rabinovitz+2 more
openaire +3 more sources
Triflouroacetic Acid as an Efficient Catalyst for the Synthesis of Quinoline [PDF]
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Ebrahim Soleimani+2 more
openaire +2 more sources
Renal gluconeogenesis effects of quinolinic acid
Biochimica et Biophysica Acta (BBA) - General Subjects, 1972Abstract Quinolinic acid, a metabolic degradation product of tryptophan metabolism and a known inhibitor of hepatic gluconeogenesis in vivo, has been shown in the present studies to inhibit renal gluconeogenesis in vitro. At pH 7.4 quinolinic acid decreased glucose production from glutamine and glutamate by rat renal cortex by more than 50%.
Anton C. Schoolwerth, Saulo Klahr
openaire +3 more sources
Neuropharmacology of quinolinic and kynurenic acids.
Pharmacological Reviews, 1993In a little more than 10 years, the kynurenine metabolites of tryptophan have emerged from their former position as biochemical curiosities, to occupy a prominent position in research on the causes and treatment of several major CNS disorders. The pathway includes two compounds, quinolinic acid and kynurenic acid, which are remarkably specific in their
openaire +2 more sources